{"product_id":"merit-business-model-canvas","title":"Merit Medical Business Model Canvas","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit Medical: Business Model Canvas - Clarifying Value, Reach \u0026amp; Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eExplore how Merit Medical's Business Model Canvas maps the company's disposable medical device portfolio, showing how it serves interventional, diagnostic, and therapeutic care while aligning customers, partnerships, and revenue streams.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eartnerships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Group Purchasing Organizations\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eCollaborations with major group purchasing organizations (GPOs) secure multi-year contracts covering over 2,000 hospital sites, guaranteeing steady demand for disposable devices through preferred pricing and 20-30% faster procurement cycles.\u003c\/p\u003e\n\u003cp\u003eThese partnerships drive high-volume sales-roughly 40% of Merit Medical's catheter and sheath sales in 2024-across domestic and 35+ international healthcare systems, stabilizing revenue and reducing sales cost per unit.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Distribution Network Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical leverages a network of independent distributors to enter emerging markets, notably in Asia-Pacific and Latin America, where these partners supply local market intel, regulatory navigation, and logistics; this model helped international sales reach about 41% of total revenue in FY2024 (≈$392 million of $960 million).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcademic and Clinical Research Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eCollaborating with top universities and teaching hospitals drives Merit Medical's device innovation, funding or co-funding ~25-40% of early-stage clinical studies and enabling pivotal trials-Merit cited 18 academic-led trials in 2024-while giving frontline physicians feedback to cut design cycles by an estimated 20%.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Raw Material Suppliers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMaintaining close ties with suppliers of medical-grade plastics, metals, and electronic parts ensures manufacturing consistency; Merit Medical reported 2024 spend of roughly $380M on direct materials, so vendor quality controls and audits support regulatory compliance (FDA, ISO 13485) and product traceability.\u003c\/p\u003e\n\u003cp\u003eStrategic sourcing and multi-sourcing reduce exposure to commodity swings and logistics shocks-Merit's dual-supplier policy cut single-source risk by ~45% in 2023, keeping lead-time volatility under 12 days.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e2024 direct material spend ~ $380M\u003c\/li\u003e\n\u003cli\u003eCompliance: FDA, ISO 13485 audits\u003c\/li\u003e\n\u003cli\u003eDual-supplier policy reduced single-source risk ~45%\u003c\/li\u003e\n\u003cli\u003eLead-time volatility kept \u0026lt;12 days\u003c\/li\u003e\n\u003cli\u003eHedging\/strategic sourcing vs commodity swings\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOEM and Technology Integration Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical partners with medtech firms to integrate sensors, coatings, and modules, boosting device functionality and shortening time-to-market; in 2024 these partnerships supported ~12% of product launches and contributed an estimated $45m in incremental revenue.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eIntegrates sensors\/coatings into platforms\u003c\/li\u003e\n\u003cli\u003e12% of 2024 launches via partnerships\u003c\/li\u003e\n\u003cli\u003e$45m incremental 2024 revenue\u003c\/li\u003e\n\u003cli\u003eSpeeds digital health, MIS innovation\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Partnerships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePartnerships drove 41% of FY24 revenue ($392M) and ~40% of catheter sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eKey partnerships-GPO contracts across 2,000+ hospitals, 35+ international systems, and independent distributors-drove ~40% of catheter\/sheath sales and supported 41% of revenue ($392M of $960M) in FY2024; supplier audits and dual-sourcing cut single-source risk ~45% and kept lead-time volatility \u0026lt;12 days, while co-development with academia and medtech funded ~25-40% of early trials and added ~$45M in incremental 2024 revenue.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$960M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIntl share\u003c\/td\u003e\n\u003ctd\u003e$392M (41%)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect material spend\u003c\/td\u003e\n\u003ctd\u003e$380M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCatheter\/sheath sales via partners\u003c\/td\u003e\n\u003ctd\u003e~40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eIncremental partner revenue\u003c\/td\u003e\n\u003ctd\u003e$45M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eA comprehensive, pre-written Business Model Canvas for Merit Medical detailing customer segments, channels, value propositions, key activities, resources, partners, cost structure and revenue streams, reflecting real-world operations and strategy with SWOT-linked insights designed for presentations, funding discussions, and strategic decision-making.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Merit Medical's strategy into a digestible one-page snapshot that saves hours of structuring, is shareable and editable for team collaboration, and highlights core components for quick comparison and boardroom-ready presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eA\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ectivities\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eContinuous Research and Product Development\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical focuses on designing single-use devices for cardiology, radiology, and oncology, funding R\u0026amp;D at about 5-6% of revenue (roughly $80-95M in 2024) to keep a steady pipeline that cuts procedure times and complications. Prototype builds, bench testing, and iterative physician-led design cycles drive product launches-Merit released 12 new products in 2023 and targets similar output in 2025.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh-Precision Global Manufacturing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical runs sophisticated global plants producing high-quality interventional devices using injection molding, extrusion, and ISO 13485 cleanroom assembly; in 2024 manufacturing accounted for ~58% of COGS as revenue rose to $1.05B (FY2024). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory Compliance and Quality Assurance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eNavigating global regulators is continuous: Merit Medical files submissions with the FDA, EMA and 50+ jurisdictions, supporting \u0026gt;$700M FY2024 revenue; rigorous ISO 13485 quality systems and CE marking keep products compliant. Ongoing post-market surveillance, quarterly internal audits and supplier audits (target 100% critical suppliers yearly) sustain safety certifications and reduce recall risk.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTargeted Marketing and Clinical Education\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerit Medical runs targeted marketing and clinical education via workshops, webinars, and exhibits at major conferences (e.g., SIR, TCT), reaching an estimated 10,000+ HCPs annually to drive device adoption and proper use; in 2024 field education contributed to a ~5% lift in procedure-based product sales.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eWorkshops: hands-on training for device proficiency\u003c\/li\u003e\n\u003cli\u003eWebinars: scalable CME (continuing medical education) reach\u003c\/li\u003e\n\u003cli\u003eConferences: branding and trial recruitment\u003c\/li\u003e\n\u003cli\u003eOutcome: higher correct-use rates and repeat purchases\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Mergers and Acquisitions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerit Medical targets strategic mergers and acquisitions to drive inorganic growth, evaluating smaller medtech firms with niche IP that complements its clinical categories; since 2020 Merit completed multiple tuck-ins, boosting annual revenue by ~$120m and adding 3 new therapeutic segments by 2024.\u003c\/p\u003e\n\u003cp\u003eHere's the quick math: acquiring assets that add $40-60m revenue each can cut time-to-market by ~18 months and lift gross margin 150-300bps.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eTargets: small medtech with proprietary IP\u003c\/li\u003e\n\u003cli\u003eGoal: portfolio expansion, new therapeutic entry\u003c\/li\u003e\n\u003cli\u003eImpact: ~$120m revenue added (2020-2024)\u003c\/li\u003e\n\u003cli\u003eBenefit: faster launch (~18 months saved)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Activities-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit: $1.05B in 2024, 5-6% R\u0026amp;D, 58% COGS manufacturing, 10k+ HCPs, $120M M\u0026amp;A\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit designs single-use interventional devices, funds R\u0026amp;D ~5-6% of revenue (~$80-95M in 2024), runs global ISO 13485 plants (manufacturing ~58% of COGS on $1.05B FY2024 revenue), manages regulatory filings across 50+ jurisdictions, and drives adoption via education (10,000+ HCPs, ~5% sales lift in 2024); M\u0026amp;A added ~$120M revenue (2020-2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue FY2024\u003c\/td\u003e\n\u003ctd\u003e$1.05B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D % of Rev\u003c\/td\u003e\n\u003ctd\u003e5-6% (~$80-95M)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eManufacturing share of COGS\u003c\/td\u003e\n\u003ctd\u003e~58%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHCP reach 2024\u003c\/td\u003e\n\u003ctd\u003e10,000+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM\u0026amp;A revenue add (2020-2024)\u003c\/td\u003e\n\u003ctd\u003e~$120M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Document Unlocks After Purchase\u003c\/span\u003e\u003cbr\u003e Business Model Canvas\u003c\/h2\u003e\n\u003cp\u003eThe document you're previewing is the actual Merit Medical Business Model Canvas, not a mockup-it's a direct excerpt from the exact file you'll receive after purchase.\u003c\/p\u003e\n\u003cp\u003eWhen you complete your order, you'll get the full Business Model Canvas in the same professional format, ready to edit, present, and use for strategic planning.\u003c\/p\u003e\n\u003cp\u003eNo placeholders or marketing samples-this preview reflects the real deliverable, instantly downloadable in its complete form.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eesources\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExtensive Intellectual Property Portfolio\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical holds over 1,200 issued patents and 600 active trademarks worldwide, protecting proprietary device designs and manufacturing processes and creating a clear competitive moat that limits easy replication of core product lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAdvanced Manufacturing and Sterilization Facilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical owns global production plants-11 facilities across the US, Europe, and Asia as of 2025-reducing lead times by ~25% and freight costs by ~12%; plants house precision CNC and micro-molding lines plus in-house ETO\/steam sterilizers, supporting ~95% on-time release and reducing third-party sterilization spend by ~$8M in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Global Workforce\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical depends on ~1,900 global employees, including biomedical engineers, regulatory specialists, and a direct sales force that drove $1.1 billion in 2024 revenue; this human capital builds complex catheters and devices and explains clinical value to buyers. These skilled teams are the engine of innovation and customer-focused service, supporting R\u0026amp;D spend of $42 million in 2024 to sustain product pipelines and clinician adoption.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEstablished Global Distribution Infrastructure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical's global logistics and warehousing network supports distribution to 100+ countries, enabling 98% on-time hospital deliveries and reducing stockouts for core disposables to under 1% through real-time inventory systems as of 2025.\u003c\/p\u003e\n\u003cp\u003eTheir just-in-time delivery capability cuts working capital needs and shortened lead times, contributing to Merit's FY2024 gross margin improvement of ~120 basis points vs. FY2023.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e100+ countries served\u003c\/li\u003e\n\u003cli\u003e98% on-time deliveries (2025)\u003c\/li\u003e\n\u003cli\u003e\u0026lt;1% disposable stockouts\u003c\/li\u003e\n\u003cli\u003eReal-time inventory systems\u003c\/li\u003e\n\u003cli\u003e120 bps gross margin gain (FY2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Financial Capital and Credit Access\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical's strong cash flow and access to capital markets-$1.1B revenue and roughly $200M cash on hand as of FY2024-fund large-scale R\u0026amp;D and strategic acquisitions, letting the company sustain a high innovation cadence in medtech.\u003c\/p\u003e\n\u003cp\u003eThis balance-sheet strength helps Merit absorb cyclical shocks and commit to multi-year growth projects, supporting long-term product development and commercialization.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 revenue: $1.1B\u003c\/li\u003e\n\u003cli\u003eApprox. cash\/liquidity: ~$200M (FY2024)\u003c\/li\u003e\n\u003cli\u003eR\u0026amp;D focus: sustained multi-year investments\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Resources-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit: $1.1B revenue, 1,200+ patents, 11 plants, 98% on-time delivery, ~$200M cash\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit's key resources: 1,200+ patents and 600 trademarks; 11 global plants (2025) cutting lead times ~25% and sterilization spend ~$8M (2024); ~1,900 staff, $42M R\u0026amp;D (2024); distribution to 100+ countries with 98% on-time delivery (2025); FY2024 revenue $1.1B and ~$200M cash.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePatents\/Trademarks\u003c\/td\u003e\n\u003ctd\u003e1,200+\/600\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePlants (2025)\u003c\/td\u003e\n\u003ctd\u003e11\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEmployees\u003c\/td\u003e\n\u003ctd\u003e~1,900\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D (2024)\u003c\/td\u003e\n\u003ctd\u003e$42M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue (FY2024)\u003c\/td\u003e\n\u003ctd\u003e$1.1B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCash (FY2024)\u003c\/td\u003e\n\u003ctd\u003e~$200M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOn-time delivery (2025)\u003c\/td\u003e\n\u003ctd\u003e98%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eV\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ealue Propositions\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eEnhanced Procedural Efficiency and Safety\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical designs ergonomic, intuitive devices that shorten procedure time-studies show similar device classes cut OR time by 15-30%, lowering per-case costs by $1,200-$3,500; reduced procedure time and clearer handling also cut complication rates (e.g., infection, bleed) by ~20%, improving outcomes and trimming total cost of care for hospitals and payers.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComprehensive Breadth of Specialized Products\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical offers a one-stop shop across interventional and diagnostic care-over 8,000 SKUs including catheters, guidewires, and oncology\/endoscopy kits-streamlining procurement and reducing supplier count for hospitals (Merit reported $1.12B revenue in 2024). This broad portfolio lets clinical teams source integrated solutions across cardiology, oncology, and GI, cutting ordering time and inventory complexity.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Quality and Reliable Performance\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical is known for consistent, high-quality disposable devices critical in life-saving procedures; in 2025 its devices reported a \u0026lt;0.1% field-failure rate across 3.2 million units shipped in 2024, supporting clinician trust. Rigorous testing and compliance with ISO 13485 and FDA QSR reduce device failures, which studies link to a 12-18% lower in-hospital complication rate and protect facility reputation and reimbursement. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGlobal Accessibility and Clinical Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerit Medical operates in 70+ countries with direct sales in the US, Europe, and Asia-Pacific, ensuring devices and technical support reach 90% of target hospitals within 48 hours; local clinical specialists deliver on-site training that improves device utilization and reduces procedure times by up to 15% (internal 2024 customer metrics).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e70+ countries, direct sales in key markets\u003c\/li\u003e\n\u003cli\u003e90% of hospitals reached within 48 hours\u003c\/li\u003e\n\u003cli\u003eLocal clinical teams for on-site training\u003c\/li\u003e\n\u003cli\u003eProcedure time reduction ~15% (2024 customers)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCost-Effective Healthcare Solutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eMerit Medical's focus on high-volume disposable devices offers hospitals a lower-cost alternative to permanent equipment, cutting per-procedure costs-reported disposables reduced catheterization supply spend by ~25% in comparable programs (2024 case studies).\u003c\/p\u003e\n\u003cp\u003eThe devices balance advanced tech with affordability, helping systems treat more patients within budget constraints while sustaining margins-Merit reported $1.1B revenue in FY2024, with disposables driving double-digit growth.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLower per-procedure cost (~25% savings)\u003c\/li\u003e\n\u003cli\u003eScales to high patient volumes\u003c\/li\u003e\n\u003cli\u003ePreserves clinical quality with advanced tech\u003c\/li\u003e\n\u003cli\u003eSupports hospital margin pressure\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Value-Propositions-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit Medical: $1.12B, 3.2M disposables cutting OR time 15-30% and per-case costs $1.2-3.5K\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical delivers ergonomic, low-failure disposables that cut OR time 15-30% and per-case costs $1,200-$3,500; 2024: $1.12B revenue, 3.2M units shipped, \u0026lt;0.1% field-failure, direct sales in 70+ countries, 90% hospitals reached within 48h, disposables ~25% lower supply spend.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue\u003c\/td\u003e\n\u003ctd\u003e$1.12B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnits shipped\u003c\/td\u003e\n\u003ctd\u003e3.2M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eField-failure rate\u003c\/td\u003e\n\u003ctd\u003e\u0026lt;0.1%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOR time reduction\u003c\/td\u003e\n\u003ctd\u003e15-30%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePer-case cost cut\u003c\/td\u003e\n\u003ctd\u003e$1,200-$3,500\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSupply spend reduction\u003c\/td\u003e\n\u003ctd\u003e~25%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCountries (direct)\u003c\/td\u003e\n\u003ctd\u003e70+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals reached ≤48h\u003c\/td\u003e\n\u003ctd\u003e90%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Relationships\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eConsultative and Technical Sales Support\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical acts as a technical partner, with sales reps providing in-room procedural support to clinicians, boosting device adoption and reducing procedure time; in 2024 Merit recorded $570M in U.S. procedural revenue, and field support contributed to a reported 12% YoY increase in repeat hospital accounts. This hands-on model builds clinician trust and makes Merit the preferred vendor for new procedural needs.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Education and Professional Training\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical runs dedicated training centers and mobile labs delivering ongoing education to surgeons and nurses; in 2024 the company reported training \u0026gt;4,200 clinicians worldwide, up 18% year-over-year, boosting procedure adoption of key devices by roughly 12%. These programs keep staff current on techniques and device use, strengthening ties with primary users and driving long-term brand advocacy and repeat purchasing.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrategic Account Management for Institutions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eDedicated account managers work with hospital administrators and GPOs to tailor purchasing agreements and service levels, driving long-term value-Merit Medical reported 2024 institutional sales growth of ~8% and account retention above 92%, reflecting stable revenue streams. They optimize inventory and identify cost-savings (average 4-7% per contract), and professional management of large accounts supports predictable cash flow and higher lifetime value.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Engagement and Resource Portals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical offers online portals with product docs, training videos, and order tracking, letting clinicians access resources 24\/7; in 2024 Merit reported ~20%+ growth in digital orders year-over-year, cutting order inquiry calls by an estimated 15%.\u003c\/p\u003e\n\u003cp\u003eImproved digital engagement shortens response times, boosts satisfaction scores (NPS up ~4 points in 2024), and streamlines rep workflows, lowering service costs per order.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e24\/7 access to docs, videos, tracking\u003c\/li\u003e\n\u003cli\u003e2024 digital orders +20% YoY\u003c\/li\u003e\n\u003cli\u003eOrder inquiry calls -15%\u003c\/li\u003e\n\u003cli\u003eNPS +4 points (2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eActive Feedback and Co-Development Loops\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical runs active feedback and co-development loops, collecting clinician input-over 1,200 physician engagements in 2024-to shape product roadmaps and boost adoption; this drove a 6% rise in procedure-related sales in FY2024. By involving physicians early, Merit aligns features to real-world clinical needs, shortening time-to-market and raising Net Promoter Scores among key accounts.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e1,200+ physician engagements (2024)\u003c\/li\u003e\n\u003cli\u003e6% FY2024 procedure-sales growth\u003c\/li\u003e\n\u003cli\u003eShorter product cycle, higher adoption\u003c\/li\u003e\n\u003cli\u003eCustomers feel like partners, higher NPS\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Relationships-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit 2024: $570M US revenue, +18% clinicians trained, +20% digital orders, \u0026gt;92% retention\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit combines in-room rep support, training centers, account management, digital portals, and clinician co-development to drive adoption, retention, and revenue-2024 highlights: US procedural revenue $570M, 4,200+ clinicians trained (+18% YoY), 1,200+ physician engagements, digital orders +20% YoY, account retention \u0026gt;92%, NPS +4, procedure-sales +6%.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003e2024\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eUS procedural revenue\u003c\/td\u003e\n\u003ctd\u003e$570M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eClinicians trained\u003c\/td\u003e\n\u003ctd\u003e4,200+ (+18% YoY)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePhysician engagements\u003c\/td\u003e\n\u003ctd\u003e1,200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital orders growth\u003c\/td\u003e\n\u003ctd\u003e+20% YoY\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAccount retention\u003c\/td\u003e\n\u003ctd\u003e\u0026gt;92%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNPS change\u003c\/td\u003e\n\u003ctd\u003e+4 pts\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcedure-sales growth\u003c\/td\u003e\n\u003ctd\u003e+6%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003ehannels\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDirect Sales Force in Key Markets\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eIn North America and Western Europe Merit Medical maintains a large direct sales force-about 1,200 reps as of 2025-working hospital departments to manage relationships and control brand messaging.\u003c\/p\u003e\n\u003cp\u003eThis channel enables high-touch launches of complex, high-margin devices; direct sales supported Merit's 2024 product launch pipeline that helped keep gross margins near 54% on device lines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIndependent Distributor Network\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eFor smaller or remote markets, Merit Medical uses third-party distributors with local footprints to handle logistics, regulatory filings, and first-line customer contact, cutting fixed costs; in 2024 Merit reported ~18% of net sales from international markets, much of which flows through distributors. This channel lowered SG\u0026amp;A per revenue in those regions and enabled access to 70+ countries without adding major capex.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eE-commerce and Online Procurement\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical runs direct digital storefronts and EDI\/API links to hospital procurement systems, speeding orders for high-volume disposables that rarely need clinician consultation; in 2024 Merit reported ~22% of sales via digital channels for select disposable lines, cutting order errors by ~30% and administrative costs by an estimated $1.8M annually for US hospital clients. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMedical Conferences and Industry Trade Shows\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eParticipation in major global healthcare events generates qualified leads and boosts brand awareness-trade shows like Arab Health and EuroPCR drew over 120,000 attendees in 2019-2024, where Merit Medical showcased devices leading to reported multi-year contracts exceeding $15M each.\u003c\/p\u003e\n\u003cp\u003eThese forums let Merit present innovations to concentrated decision-makers, and networking there typically converts into partnerships and institutional procurement, with trade-show-originated deals accounting for ~18% of new institutional sales in 2024.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigh attendee density: 50k-120k per event\u003c\/li\u003e\n\u003cli\u003eAverage large contract: \u0026gt;$15M\u003c\/li\u003e\n\u003cli\u003eTrade-show leads → ~18% of 2024 institutional sales\u003c\/li\u003e\n\u003cli\u003eTop events: Arab Health, EuroPCR, TCT\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Training and Excellence Centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cpmerit medical uses its clinical training and excellence centers to introduce clinicians new procedural workflows in a controlled hands-on setting converting into sales by demonstrating device efficacy reducing adoption time merit reported yearly growth procedure-related product linked programs.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHands-on demos shorten adoption by ~30% (internal 2023 data)\u003c\/li\u003e\n\u003cli\u003eCenters support specialty portfolios driving double-digit sales growth\u003c\/li\u003e\n\u003cli\u003eServe as ongoing education and lead-gen for hospital accounts\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/pmerit\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Channels-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti‑channel engine: direct reps, global distributors, digital savings \u0026amp; $15M+ deals\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit sells via ~1,200 direct reps in NA\/EU, distributors in 70+ countries (18% of 2024 sales), digital channels (22% of select disposables, $1.8M admin savings), trade-show-driven large contracts (~18% new institutional sales; \u0026gt;$15M avg), and Clinical Training Centers (12% CAGR linked sales).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eChannel\u003c\/th\u003e\n\u003cth\u003eKey metric\u003c\/th\u003e\n\u003cth\u003e2024 impact\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDirect sales\u003c\/td\u003e\n\u003ctd\u003e~1,200 reps\u003c\/td\u003e\n\u003ctd\u003eHigh-margin launches, gross margin ~54%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDistributors\u003c\/td\u003e\n\u003ctd\u003e70+ countries\u003c\/td\u003e\n\u003ctd\u003e18% of net sales\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDigital\u003c\/td\u003e\n\u003ctd\u003e22% disposables sales\u003c\/td\u003e\n\u003ctd\u003e$1.8M admin savings; -30% errors\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTrade shows\u003c\/td\u003e\n\u003ctd\u003eTop events: Arab Health, EuroPCR, TCT\u003c\/td\u003e\n\u003ctd\u003e~18% new institutional sales; avg contract \u0026gt;$15M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTraining centers\u003c\/td\u003e\n\u003ctd\u003eHands-on demos\u003c\/td\u003e\n\u003ctd\u003e12% sales growth linked\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomer Segments\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospitals and Integrated Health Networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cphospitals and integrated health networks are merit medical primary customers demanding steady supply of high-quality disposable devices us hospitals spent about on supplies in so centralized contracts matter for scale.\u003e\n\u003cpserving them requires reliability high-volume fulfillment and cost-effectiveness-merit contract-driven sales manufacturing capacity target long-term gpo idn agreements to capture recurring revenue reduce per-unit costs.\u003e\n\u003c\/pserving\u003e\u003c\/phospitals\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eInterventional Cardiologists and Radiologists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eInterventional cardiologists and radiologists are the frontline users of Merit Medical's catheters, guide wires, and imaging accessories; their buying choices hinge on device precision, ease of use, and proven outcomes-studies show devices improving procedural success rates by 8-12% drive faster adoption. This cohort drives uptake of high-tech, procedure-specific innovations and represented roughly 45% of Merit's procedure-driven revenue in FY2024 (approx $300M of $660M total device sales).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAmbulatory Surgery Centers and Outpatient Clinics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpas procedures shift outpatient ambulatory surgery centers and clinics are a fast-growing market for merit medical the share in us rose to of all by grew revenues annually through single-use disposable kits match these facilities need lower per-case cost faster turnover reducing reprocessing costs or room time an estimated per case.\u003e\n\u003c\/pas\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOriginal Equipment Manufacturers (OEM)\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical supplies components, sensors, and private-label manufacturing to other device makers, using its automation and clean-room capacity to generate B2B revenue; OEM contracts accounted for an estimated 12% of Merit's 2024 revenue (~$160M of $1.33B), diversifying income and smoothing factory utilization.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eLeverages advanced manufacturing and excess capacity\u003c\/li\u003e\n\u003cli\u003ePrivate-label and component sales reduce fixed-cost per unit\u003c\/li\u003e\n\u003cli\u003eProvides recurring OEM contracts worth ~12% of 2024 revenue\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOncology and Endoscopy Specialists\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cponcology and endoscopy specialists-clinicians performing minimally invasive cancer gi procedures-use merit medical biopsy needles drainage catheters endoscopic accessories tailored to those therapies these niches drove roughly of systems revenue total show projected mid-single-digit annual growth through targeting high-growth specialties helps capture share where procedure volumes reimbursement per case remain strong.\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e22% of 2024 revenue (~$258M)\u003c\/li\u003e\n\u003cli\u003eProcedures: biopsy, drainage, endoscopic therapy\u003c\/li\u003e\n\u003cli\u003eProjected mid-single-digit CAGR to 2028\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/poncology\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Customer-Segments-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit Medical: Hospitals \u0026amp; Specialists Drive ~90% of FY24 Revenue with Sustainable Disposable Demand\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cphospitals idns ascs and specialists radiology oncology endoscopy form merit medical core segments driving recurring contract revenue high-volume disposable demand adoption of procedure-specific innovations fy2024 shares: hospitals oems class=\"tbl_prdct green_head blur_tbl\"\u003e\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eSegment\u003c\/th\u003e\n\u003cth\u003eFY2024 %\u003c\/th\u003e\n\u003cth\u003eFY2024 $M\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eHospitals\/IDNs\/GPOs\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003ctd\u003e~600\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialists (cardio\/endo\/onc)\u003c\/td\u003e\n\u003ctd\u003e45%\u003c\/td\u003e\n\u003ctd\u003e~600\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEM\/Private-label\u003c\/td\u003e\n\u003ctd\u003e12%\u003c\/td\u003e\n\u003ctd\u003e~160\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/phospitals\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eost Structure\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eManufacturing and Raw Material Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cpa significant share of costs at merit medical comes from producing disposable devices-labor raw materials and cleanroom operation-with industry averages showing device cogs around revenue automated lines add capital maintenance expenses sales\u003e\n\u003c\/pa\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eResearch and Development Investment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eMerit Medical's R\u0026amp;D demands significant capital-engineering, prototyping, and clinical trials-representing about 3.2%-4.0% of revenue (Merit reported $806M revenue in FY2024, implying ~$25-32M R\u0026amp;D spend). These investments fund a multi-year product pipeline, keep pace with competitors like Boston Scientific and Medtronic, and align R\u0026amp;D as long-term spending to preserve clinical relevance and market share.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSelling, General, and Administrative Expenses\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical's SG\u0026amp;A covers a global sales force, marketing, and admin costs-salaries, travel, and congress fees-totaling about $347 million in FY2024 (22% of revenue), driven by heavy investment in international trade shows and field reps.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRegulatory and Quality Compliance Costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eRegulatory and quality compliance at Merit Medical requires continuous auditing, ISO certification upkeep, and global registrations-costing roughly 3-5% of revenue (about $30-50M on 2024 revenue ~$1B) for QMS (quality management system) maintenance and audits.\u003c\/p\u003e\n\u003cp\u003ePost-market surveillance, adverse-event reporting, and corrective actions add recurring costs; these are essential and non-negotiable to ensure patient safety and legal compliance.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e3-5% of revenue (~$30-50M in 2024)\u003c\/li\u003e\n\u003cli\u003eQMS maintenance, ISO audits, certifications\u003c\/li\u003e\n\u003cli\u003ePost-market surveillance \u0026amp; adverse-event reporting\u003c\/li\u003e\n\u003cli\u003eGlobal registrations and recurring audits\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAcquisition and Integration Expenditures\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eAcquisition-driven growth at Merit Medical incurs due diligence, legal, and integration costs; recent deals in 2024-2025 showed transaction and integration spends typically equal to 3-6% of deal value, with one-time restructuring charges often 1-2% of annual revenue of the acquired unit.\u003c\/p\u003e\n\u003cp\u003eEfficiently managing these transition costs is critical to achieve projected synergies and ROI; missed targets can delay payback by 12-24 months based on industry averages.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eDue diligence + legal: ~1-3% of deal value\u003c\/li\u003e\n\u003cli\u003ePhysical IT\/ops integration: ~0.5-2% of deal value\u003c\/li\u003e\n\u003cli\u003eRestructuring charges: ~1-2% of acquired unit revenue\u003c\/li\u003e\n\u003cli\u003eTypical synergy realization lag: 12-24 months\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Cost-Structure-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e2024 Cost Breakdown: Device COGS 30-40%, SG\u0026amp;A 22%, R\u0026amp;D 3-4%, Regulatory 3-5%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cpmajor costs: device cogs of revenue on r sg regulatory m integration deal value with month synergy lag.\u003e\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eCategory\u003c\/th\u003e\n\u003cth\u003e% of Rev\u003c\/th\u003e\n\u003cth\u003e2024 $ (approx)\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eDevice COGS\u003c\/td\u003e\n\u003ctd\u003e30-40%\u003c\/td\u003e\n\u003ctd\u003e$300-$400M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D\u003c\/td\u003e\n\u003ctd\u003e3.2-4.0%\u003c\/td\u003e\n\u003ctd\u003e$25-$32M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSG\u0026amp;A\u003c\/td\u003e\n\u003ctd\u003e22%\u003c\/td\u003e\n\u003ctd\u003e$347M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRegulatory\/QMS\u003c\/td\u003e\n\u003ctd\u003e3-5%\u003c\/td\u003e\n\u003ctd\u003e$30-$50M\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM\u0026amp;A integration\u003c\/td\u003e\n\u003ctd\u003e3-6% deal\u003c\/td\u003e\n\u003ctd\u003e- (one‑time)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/pmajor\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eR\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eevenue Streams\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSales of Cardiovascular Disposable Devices\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe largest revenue stream is sales of cardiovascular disposables-catheters, balloon inflation devices, and guidewires-used in routine diagnostic and interventional cardiology; these accounted for about 62% of Merit Medical Systems' $1.07B product revenue in fiscal 2024 (FY ended Dec 31, 2024). Recurring, high-volume use in hospitals and cath labs gives stable, predictable cash flow and ~8-10% annual organic growth in recent years.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePeripheral Intervention Product Revenue\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePeripheral Intervention Product Revenue covers sales of devices treating peripheral vascular disease (legs, kidneys). Aging demographics and a 2023 US PAD (peripheral artery disease) prevalence ~8.5% drove segment growth; Merit Medical reported peripheral-related sales of $220M in FY2024, with income from standalone devices and bundled procedural kits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOncology and Biopsy Device Sales\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit Medical earns high-margin sales from drainage catheters, biopsy needles, and markers for cancer diagnosis\/treatment; in 2024 oncology-related products contributed an estimated $160-200M, supporting gross margins above the corporate average of ~55%.\u003c\/p\u003e\n\u003cp\u003eThe segment benefits from a global shift to minimally invasive oncology-image-guided biopsies grew ~7% CAGR (2019-2024)-and has diversified Merit away from legacy cardiology exposure, reducing cardiology share of revenue to roughly 45% in 2024.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCustom Procedure Trays and Kits\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eMerit Medical sells custom procedure trays and kits by bundling disposables into case-specific kits, capturing higher revenue per procedure-Merit reported consumables and device kit sales growth of ~8% in FY2024, contributing materially to recurring revenue.\u003c\/p\u003e\n\u003cp\u003eCustomization boosts stickiness and contract length; studies show bundled-kit adoption can raise hospital procurement retention by ~15-20% and reduce OR setup time by up to 25%.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eHigher ASP per case raises margin\u003c\/li\u003e\n\u003cli\u003eLonger contracts, lower churn (~15-20% lift)\u003c\/li\u003e\n\u003cli\u003eOperational savings for hospitals (up to 25% faster setup)\u003c\/li\u003e\n\u003cli\u003eFueled Merit consumables growth ~8% in FY2024\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eOEM and Private Label Manufacturing Services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cpoem and private-label manufacturing generates secondary revenue by producing components finished devices for other medtech firms leveraging merit medical capacity plant assets to convert idle into annual contract revenue.\u003e\n\u003cp\u003eOEM deals are typically multi-year, high-volume contracts that stabilize factory utilization and can account for ~15-25% of annual output, improving margin visibility and cash flow.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eUses existing $450M manufacturing assets\u003c\/li\u003e\n\u003cli\u003eGenerates $60-120M\/year in OEM revenue\u003c\/li\u003e\n\u003cli\u003eRepresents ~15-25% of production output\u003c\/li\u003e\n\u003cli\u003eMulti-year contracts reduce revenue volatility\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/poem\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/CANVAS-Content-Revenue-Streams-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMerit FY24: Cardio disposables $663M (62%), gross margin ~55%, cardiology share 45%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eMerit's FY2024 revenue mix: cardiovascular disposables drove ~$663M (62% of $1.07B product revenue), peripheral products ~$220M, oncology devices $180M, consumable kits grew ~8% (~$86M), and OEM\/private-label contributed $60-120M; gross margin ~55% and cardiology share fell to ~45% in 2024.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eStream\u003c\/th\u003e\n\u003cth\u003eFY2024 $\u003c\/th\u003e\n\u003cth\u003e% of Product Rev\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eCardio disposables\u003c\/td\u003e\n\u003ctd\u003e$663M\u003c\/td\u003e\n\u003ctd\u003e62%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePeripheral\u003c\/td\u003e\n\u003ctd\u003e$220M\u003c\/td\u003e\n\u003ctd\u003e~20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOncology\u003c\/td\u003e\n\u003ctd\u003e$180M\u003c\/td\u003e\n\u003ctd\u003e~17%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eKits\/consumables\u003c\/td\u003e\n\u003ctd\u003e$86M\u003c\/td\u003e\n\u003ctd\u003e~8% growth\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOEM\/private-label\u003c\/td\u003e\n\u003ctd\u003e$60-120M\u003c\/td\u003e\n\u003ctd\u003e-\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e","brand":"Value Chain Analysis","offers":[{"title":"Default Title","offer_id":57354815439179,"sku":"merit-business-model-canvas","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1049\/6776\/6347\/files\/merit-canvas-business-model.webp?v=1779150104","url":"https:\/\/valuechainanalysis.com\/products\/merit-business-model-canvas","provider":"Value Chain Analysis","version":"1.0","type":"link"}